| 注册
首页|期刊导航|中国药房|3种丹参制剂治疗冠心病心绞痛的成本-效果分析

3种丹参制剂治疗冠心病心绞痛的成本-效果分析

杨文波

中国药房2011,Vol.22Issue(11):1033-1034,2.
中国药房2011,Vol.22Issue(11):1033-1034,2.

3种丹参制剂治疗冠心病心绞痛的成本-效果分析

Cost-effectiveness Analysis of 3 Kinds of Salvia miltiorrhiza Preparations on Angina Pectoris of Coronary Heart Disease

杨文波1

作者信息

  • 1. 延边大学附属医院药剂科,延吉市,133000
  • 折叠

摘要

Abstract

OBJECTIVE: To compare the cost-effectiveness of 3 kinds of Salvia miltiorrhiza preparations on angina pectoris (AP) of coronary heart disease (CHD). METHODS: A total of 137 cases accordance with the diagnosis standard received 3 kinds of therapeutic regimen respectively: tanshione Ⅱ A sodium sulfonate injection as therapeutic regimen A; Danshen injection as therapeutic regimen B; Danshen freeze-dried powder as therapeutic regimen C, qd, i.v.gtt. The curative effects were observed after 14 days, and cost-effectiveness analysis was conducted. RESULTS: The total effective rates of 3 kinds of therapeutic regimens were 86.96% 、70.21% and 86.36%. The costs of them were 4 896.23 yuan, 3 502.33 yuan and 3 807.25 yuan. The cost-effectiveness ratios were 5 630.44, 4 988.36 and 4 408.58, respectively. CONCLUSION: Therapeutic regimen C is superior in terms of the cost-effectiveness ratios among 3 kinds therapeutic regimens.

关键词

冠心病心绞痛/丹参酮ⅡA磺酸钠注射液/丹参注射液/注射用丹参无菌粉末/成本-效果分析

分类

医药卫生

引用本文复制引用

杨文波..3种丹参制剂治疗冠心病心绞痛的成本-效果分析[J].中国药房,2011,22(11):1033-1034,2.

中国药房

OACSCDCSTPCD

1001-0408

访问量0
|
下载量0
段落导航相关论文